Abigail Chua, D.O.
NPI 1821381385 · Neurology Physician · Wilkes Barre, PA
Enrolled with Medicare as Practitioner - Neurology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1821381385
- Entity type
- Individual
- Primary specialty
- Neurology PhysicianAllopathic & Osteopathic Physicians
- Credential
- D.O.
- Sex
- Female
- Sole proprietor
- No
- License
- OT014206 (PA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
15 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
468 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 150 | $92 |
| Injection of Chemical for Paralysis of Facial and Neck Nerve Muscles on Both Sides of Face64615 | 83 | $116 |
| Injection of Anesthetic Agent And/Or Steroid Into Upper Neck and Back of Head Nerve64405 | 45 | $72 |
| Visit Complexity Inherent to Evaluation and Management Associated With Medical Care Services That Serve As the Continuing Focal Point for All Needed Health Care Services And/Or With Medical Care Services That Are Part of Ongoing Care Related to a Patient'SG2211 | 41 | $16 |
| Injection of Trigger Points, 1-2 Muscles20552 | 36 | $27 |
| Injection of Trigger Points, 3 Or More Muscles |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 30 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Galcanezumab-Gnlmbrand: Emgality Pen | 212 | 41 |
| Ubrogepantbrand: Ubrelvy | 160 | 41 |
| Baclofen | 146 | 40 |
| Topiramate | 124 | 25 |
| Sumatriptan Succinate | 98 | 20 |
| Rizatriptan Benzoatebrand: Rizatriptan | 96 | 25 |
| Rimegepant Sulfatebrand: Nurtec Odt | 89 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$175 across 2 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2011-05-17
- Last updated
- 2021-02-11
- Certified
- 2021-02-11
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.